2007 Annual
Stockholders Meeting
May 23, 2007
Financial Highlights
0.40
0.52
Diluted Earnings Per Share
3,318
4,548
Net Income
5,524
8,201
Income from Operations
27,120
31,005
Gross Profit
$63,047
$69,804
Revenues
2005
2006
in thousands, except for per share amounts
Financial Highlights
2006 Continued focus on:
Maximize operating income
Increase cash flows
Improve balance sheet
Revenue Growth
Improved Gross Margins
Reduced SG&A Expense as a
Percentage of Revenues
Maximize Operating Income
Revenue
Growth
Compound
Annual
Sales
Growth of
10.7%
Maximize Operating Income
Improve Gross
Margin
2003 38.8%
2004 42.0%
2005 43.0%
2006 44.4%
Maximize Operating Income
Reduced SG&A
Expense as a
Percentage of
Revenues
2003 32.5%
2004 31.4%
2005 30.6%
2006 29.6%
Maximize Operating Income
Improve
Operating
Margin
2003 2.6%
2004 7.6%
2005 8.8%
2006 11.7%
Maximize Operating Income
Operating
Income
2003 1,321
2004 4,303
2005 5,524
2006 8,201
Maximize Operating Income
Earnings per
Share
2003 (0.04)
2004 0.23
2005 0.40
2006 0.52
Maximize Operating Income
Increase Cash Flows
Improve Balance Sheet
Reduced Total
Debt
2003 15,563
2004 12,322
2005 6,361
2006 2,478
Increased
Current Ratio
2003 1.11
2004 1.24
2005 1.96
2006 2.10
Q1 Overview
(in thousands)
106.23%
801
754
4.6%
1,555
8.2%
Net Income
100.00%
0.09
0.09
0.18
EPS (Diluted)
56.13%
870
1,550
9.5%
2,420
12.7%
Operating
Income
5,594
34.2%
7,144
43.7%
$16,350
Q1
2006
728
1,598
$2,676
Q1 ($)
Variance
13.01%
6,322
33.2%
Operating
Expenses
22.37%
8,742
46.0%
Gross Profit
16.37%
$19,026
Net Revenues
Q1 (%)
Variance
Q1
2007
Market Performance
MEDTOX Scientific, Inc.
Update on 2006 initiatives:
The eChain® System
MEDTOXScan ® Reader
Clinical Trials Services
MEDTOX Scientific, Inc.
The eChain ® System
MEDTOX Scientific, Inc.
eChain® System
2006 Update:
Established eChain® in 1,100 clinics
Goal was 1,000 clinics
Brought national retailer with 1,500
company sites fully on-line
Added 187 other clinics or
companies
Created interface with 2 key TPA’s
MEDTOX Scientific, Inc.
(Hospital Lab / ER market)
Reader
MEDTOX Scientific, Inc.
2006 Update:
Product launch: 11/6/06
Distributed via Cardinal Health
Have placed 240 readers
Excellent client response
MEDTOX Scientific, Inc.
MEDTOX Scientific, Inc.
Clinical Trials Services
MEDTOX Scientific, Inc.
Clinical Trials Services
CTS is comprised of 3 business
units:
Central laboratory services
Bioanalytical & assay development
Bioequivalence studies
CTS is a component of our Specialty
Laboratory Services segment
CTS – Historic Growth
2007 Annual
Stockholders Meeting
May 23, 2007